Literature DB >> 16609918

Differential expression of caveolin-3 in mouse smooth muscle cells in vivo.

Hiroshi Kogo1, Shin-ya Ito, Yoshinobu Moritoki, Hiroki Kurahashi, Toyoshi Fujimoto.   

Abstract

Expression of caveolin-1 and -3 in mouse smooth muscle cells in vivo was examined by immunohistochemistry. Caveolin-1 was detected in almost all smooth muscles examined, except for the pupillary dilator muscle, whereas caveolin-3 was present only in smooth muscles of some specific tissues. In the eye, the pupillary sphincter muscle was intensely positive for caveolin-3, whereas the ciliary muscle and pupillary dilator muscle were negative. In the gastrointestinal tract, caveolin-3 was detected in the inner circular layer, but not in the outer longitudinal layer. Vascular smooth muscle cells of the resistance-sized artery in the uterus and corpus cavernosum were intensely positive for caveolin-3, whereas those of the aorta were only weakly positive and those of the vena cava were negative. Caveolin-3 was also detected in smooth muscle cells of the urinary bladder, ureter, prostatic vas deferens, and seminal vesicle. The different levels of caveolin-3 expression among various smooth muscle tissues were confirmed by Western blot analysis. Even within the same muscle, the relative expression levels of caveolin-1 and -3 were variable among neighboring cells, suggesting distinct fine regulation of expression of these two caveolins. Moreover, even in the same cell, caveolin-1 and -3 showed different distributions. These results indicate that the two caveolins form distinct caveolae in smooth muscles, and that caveolin-1 and -3 serve different functions. Their differential expression may therefore be related to the functional diversity of smooth muscles.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16609918     DOI: 10.1007/s00441-005-0130-z

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  8 in total

1.  Cell entry of lymphocytic choriomeningitis virus is restricted in myotubes.

Authors:  Masaharu Iwasaki; Shuzo Urata; Yoshitake Cho; Nhi Ngo; Juan C de la Torre
Journal:  Virology       Date:  2014-05-05       Impact factor: 3.616

2.  Muscarinic receptor-mediated bronchoconstriction is coupled to caveolae in murine airways.

Authors:  Heike Schlenz; Wolfgang Kummer; Gitte Jositsch; Jürgen Wess; Gabriela Krasteva
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-12-18       Impact factor: 5.464

3.  Increased caveolae density and caveolin-1 expression accompany impaired NO-mediated vasorelaxation in diet-induced obesity.

Authors:  T Hilton Grayson; Preet S Chadha; Paul P Bertrand; Hui Chen; Margaret J Morris; Sevvandi Senadheera; Timothy V Murphy; Shaun L Sandow
Journal:  Histochem Cell Biol       Date:  2012-09-25       Impact factor: 4.304

4.  How antepartum and postpartum acute urinary retention affects the function and structure of the rat bladder.

Authors:  Ching-Chung Liang; Yi-Hao Lin; Tse-Ching Chen; Shuenn-Dhy Chang
Journal:  Int Urogynecol J       Date:  2014-02-11       Impact factor: 2.894

5.  Loss of bladder smooth muscle caveolae in the aging bladder.

Authors:  Samar K Lowalekar; Vivian Cristofaro; Ziv M Radisavljevic; Subbarao V Yalla; Maryrose P Sullivan
Journal:  Neurourol Urodyn       Date:  2012-02-28       Impact factor: 2.696

6.  Contractile markers distinguish structures of the mouse aqueous drainage tract.

Authors:  MinHee K Ko; James C H Tan
Journal:  Mol Vis       Date:  2013-12-16       Impact factor: 2.367

7.  A novel mouse model of anterior segment dysgenesis (ASD): conditional deletion of Tsc1 disrupts ciliary body and iris development.

Authors:  Anna-Carin Hägglund; Iwan Jones; Leif Carlsson
Journal:  Dis Model Mech       Date:  2017-03-01       Impact factor: 5.758

8.  The role of caveolae and caveolin 1 in calcium handling in pacing and contraction of mouse intestine.

Authors:  Edwin E Daniel; Tahereh Eteraf; Bettina Sommer; Woo Jung Cho; Ahmed Elyazbi
Journal:  J Cell Mol Med       Date:  2008-01-23       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.